| Name | Title | Contact Details |
|---|
Avaxia is a leader in the growing field of gut-targeted therapeutics — orally administered, minimally absorbed drugs that are designed to act locally in the gastrointestinal tract. Avaxia’s lead clinical candidate, AVX-470, is an oral anti-TNF antibody for inflammatory bowel disease. This transformative product offers potentially improved safety and efficacy over existing anti-TNF therapies by focusing immune suppression only where needed in the diseased gut. Avaxia plans to use its gut-targeted antibody platform to develop therapeutics to address many other serious diseases such as type 2 diabetes, celiac disease, GI acute radiation syndrome and oral mucositis.
Rovin Med, is a Plainfield, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Foot Levelers, Inc is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Foot Levelers, Inc is based in Roanoke, VA. You can find more information on Foot Levelers, Inc at www.footlevelers.com
AFA Capital is a Irvine, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Treatment Solutions Network is a Fort Lauderdale, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.